Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2007. Start Trial.
Date Value
November 17, 2026 1.317
November 16, 2026 1.317
November 13, 2026 1.317
November 12, 2026 1.317
November 11, 2026 1.317
November 10, 2026 1.317
November 09, 2026 1.317
November 06, 2026 1.317
November 05, 2026 1.317
November 04, 2026 1.268
November 03, 2026 1.268
November 02, 2026 1.268
October 30, 2026 1.092
October 29, 2026 1.092
October 28, 2026 1.092
October 27, 2026 1.092
October 26, 2026 1.092
October 23, 2026 1.092
October 22, 2026 1.092
October 21, 2026 1.092
October 20, 2026 1.092
October 19, 2026 1.092
October 16, 2026 1.092
October 15, 2026 1.092
October 14, 2026 1.092
Date Value
October 13, 2026 1.092
October 12, 2026 1.152
October 09, 2026 1.152
October 08, 2026 1.152
October 07, 2026 1.152
October 06, 2026 1.152
October 05, 2026 1.152
October 02, 2026 1.152
October 01, 2026 1.152
September 30, 2026 1.152
September 29, 2026 1.195
September 28, 2026 1.195
September 25, 2026 1.195
September 24, 2026 1.195
September 23, 2026 1.195
September 22, 2026 1.195
September 21, 2026 1.195
September 18, 2026 1.195
September 17, 2026 1.195
September 16, 2026 1.195
September 15, 2026 1.195
September 14, 2026 1.216
September 11, 2026 1.216
September 10, 2026 1.216
September 09, 2026 1.189

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Pharma Mar SA 4.671
Oryzon Genomics SA 2.015
Agenus, Inc. --
Amgen, Inc. 17.06
Anika Therapeutics, Inc. 1.251

Price to Book Value Related Metrics